Karus Therapeutics features in Biology Impacting Lives programme

Oxfordshire, UK, 11 October 2019 – Karus Therapeutics, a clinical-stage biopharmaceutical company developing precision medicines for cancer, was featured in the Biology Impacting Lives programme for its work towards developing precision medicines to target bile duct cancer.

The programme from ITN Productions in partnership with the Royal Society of Biology features key industry interviews and news-style reports along with sponsored editorial profiles. Introduced by National newsreader Natasha Kaplinsky, it features interviews with Karus’s Tim Edwards, Executive Chairman, Dr Philip Beer, Head of Translational Medicine, Dr Alice Gatland, Research Scientist, as well as Professor John Bridgewater, an expert in the study and treatment of bile duct cancer from University College London.